[Sarcomatoid carcinoma of the urinary tract: clinical analysis of 16 cases].
Cheng
C
Zhou
Li-Ping
LP
Xie
Xiang-Yi
XY
Zheng
D002292:Carcinoma, Renal Cell / Q000378:metabolism / Q000473:pathology / Q000601:surgery*; D002295:Carcinoma, Transitional Cell / Q000378:metabolism / Q000473:pathology / Q000601:surgery; D002296:Carcinosarcoma / Q000378:metabolism / Q000473:pathology / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007633:Keratins / Q000378:metabolism; D007680:Kidney Neoplasms / Q000473:pathology / Q000601:surgery*; D008207:Lymphatic Metastasis; D008297:Male; D011471:Prostatic Neoplasms / Q000378:metabolism / Q000473:pathology / Q000601:surgery; D012189:Retrospective Studies; D015996:Survival Rate; D014516:Ureteral Neoplasms / Q000378:metabolism / Q000473:pathology / Q000601:surgery; D001749:Urinary Bladder Neoplasms / Q000378:metabolism / Q000473:pathology / Q000601:surgery; D014571:Urologic Neoplasms / Q000378:metabolism / Q000473:pathology / Q000601:surgery*; D014746:Vimentin / Q000378:metabolism
D014746:Vimentin; D007633:Keratins